Bristol-Myers Squibb Company

Early Clinical Lead, Oncology

Location
Princeton, NJ, US
Posted
Apr 16, 2018
Ref
R1505339
Required Education
Doctorate/PHD/MD
Position Type
Full time
Bristol-Myers Squibb, Princeton, NJ USA (https://www.bms.com/) is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. As a pioneer in the field of Oncology, BMS has led the way with more cancer drugs brought to market than any other pharmaceutical company, including: Cytotoxics (cisplatin, carboplatin, paclitaxel, etoposide, teniposide, cyclophosphamide, ixabepilone, carmustine, lomustine, hydroxyurea, megestrol acetate, mitotane), Targeted Biologics (cetuximab), Small molecule targeted inhibitors (dasatanib), and most recently, Immuno-Oncology (ipilimumab, nivolumab, elotuzumab).
The mission of BMS Oncology is simple: Cure Cancer. Through the indomitable spirit and dedication of our teams to create our broad and deep pipeline of oncology agents stretching from Discovery through Development, we are committed to a relentless pursuit to develop therapeutic solutions so that no patient is left behind. We are seeking individuals who are creative and resilient with an innovative spirit who crave a challenge and want to be part of a team making history by rewriting the rules of oncology.

The Early Clinical Lead (ECL) serves as the primary clinical leader for one or more pre-clinical or clinical assets within a matrix team. The ECL reports to and is supervised by a Clinical Program Lead who supervises the entire clinical program within an Early Development Team. The ECLs key responsibilities include: Leading clinical development strategy for one or more assets and leading the design, execution, and analysis of data for one or more clinical studies.

Early Clinical Lead (ECL) Roles and Responsibilities
• Contributes to selection of discovery compounds, development of clinical strategy and transition of compounds into early phase development
• Designs and develops clinical studies and research plans in support of asset strategy. Clinical studies range from first-in-human Phase I, proof of concept Phase I/II, entry registrational studies, and clinical pharmacology studies
• Contributes to clinical strategy development and translational medicine strategy for an asset as part of a multi-functional team
• Leads the execution of clinical studies and interpretation of data and makes appropriate recommendations based on these data
• Contributes to the writing, review and publishing of reports submitted to regulatory agencies
• Builds relationships with thought leaders and principal investigators and gathers input on disease areas and design of clinical programs

Desired Background and Experience
• Qualified individuals must possess an MD, MD/PhD, PhD, or Pharm D
• Prior experience in biomedical research in academia or industry (oncology preferred)
• Ability to plan, develop, and execute early clinical development studies including selection of relevant biomarkers and pharmacodynamic endpoints. Also must have the ability to analyze, interpret, and report results
• Applicants should have strong leadership skills, yet be able to work effectively in a team environment
• Excellent communication and presentation skills are essential

Desired Background and Experience
Qualified individuals must possess an MD, MD/PhD, PhD, or Pharm D
Prior experience in biomedical research in academia or industry (oncology preferred)
Ability to plan, develop, and execute early clinical development studies including selection of relevant biomarkers and pharmacodynamic endpoints. Also must have the ability to analyze, interpret, and report results
Applicants should have strong leadership skills, yet be able to work effectively in a team environment
Excellent communication and presentation skills are essential